COMMUNIQUÉS West-GlobeNewswire

Trading by management and of close relations to management

13/02/2018 - 10:15

Please see attached for details of the transaction http://prlibrary-eu.nasdaq.com/Resource/Download/79c8b9e6-f1b0-45d0-827b-e8b1dcb5773f

Transactions in relation to share buyback program

13/02/2018 - 10:04

Acting under its share buyback authorization, the GN Store Nord board of directors initiated a share buyback program on May 4, 2017 in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]

Affimed Announces Pricing of Public Offering of Common Stock

13/02/2018 - 09:01

Heidelberg, Germany February 13, 2018 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, today announced the pricing [...]

Olainfarm to Strengthen Belarus Operations

13/02/2018 - 09:00

Olaine, 2018-02-13 09:00 CET (GLOBE NEWSWIRE) -- “Since acquisition of daughter companies we are putting a lot of effort to integrate them and use as many synergies as we can. In NPK Biotest, we have created a certified [...]

Verona Pharma Provides Clinical Development Update

13/02/2018 - 08:00

LONDON, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq: VRNA ) (Verona Pharma), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]

ERYTECH Selects Triple Negative Breast Cancer as Next Indication for Eryaspase

13/02/2018 - 07:31

ERYTECH Selects Triple Negative Breast Cancer as Next Indication for Eryaspase Set-up activities for Phase 2 clinical study ongoing and patient enrollment expected to start Q3 2018 LYON, France - February 13, 2018 - [...]

Sandoz announces US FDA approval and launch of Glatopa® 40 mg/mL three times-a-week generic option for relapsing forms of multiple sclerosis

13/02/2018 - 07:16

Glatopa ® 40 mg/mL is a fully substitutable, AP-rated generic version of Copaxone ®* (glatiramer acetate injection) 40 mg/mL Glatopa 40 mg/mL, along with Glatopa ® 20 mg/mL, which was launched in the US in June 2015, [...]

Momenta Pharmaceuticals Announces FDA Approval and Launch of Glatopa® (glatiramer acetate injection) 40 mg/mL

13/02/2018 - 07:15

--Glatopa 40 mg/mL is a fully substitutable, AP-rated generic version of three times-a-week COPAXONE ® (glatiramer acetate injection) 40 mg/mL for the treatment of patients with relapsing forms of multiple sclerosis (MS [...]

Neovacs Announces Positive Data Review from Last IDSMB Review Prior to Final Results of Phase IIb Clinical Trial of IFNalpha Kinoid in Lupus

13/02/2018 - 07:01

PRESS RELEASE · PRESS RELEASE · PRESS RELEASE Neovacs Announces Positive Data Review from Last IDSMB Review Prior to Final Results of Phase IIb Clinical Trial of IFNalpha Kinoid in Lupus Final Trial Results Expected in [...]

Néovacs annonce les conclusions positives de la dernière revue des données pour l'étude clinique de phase IIb avec l'IFNalpha Kinoïde dans le lupus par l'iDSMB

13/02/2018 - 07:01

COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE Néovacs annonce les conclusions positives de la dernière revue des données pour l'étude clinique de phase IIb avec l'IFNalpha Kinoïde dans le lupus par [...]

Orkla Food Ingredients Expands its Acrylamide-Reducing Yeast Technology Licence Agreement with Renaissance BioScience Corp.

13/02/2018 - 07:00

OSLO, Norway and VANCOUVER, British Columbia, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Orkla Food Ingredients, a business area of Orkla ASA (OSE: ORK ), and Renaissance BioScience Corp. have agreed to expand their licence [...]

Gallup and Sharecare Release 2017 State Well-Being Rankings

13/02/2018 - 06:01

WASHINGTON and ATLANTA, Feb. 13, 2018 (GLOBE NEWSWIRE) -- World-leading analytics and advice firm Gallup, and Sharecare, the digital health company helping people manage all their health in one place, today announced [...]

Daré Bioscience, Inc. Announces Proposed Public Offering of Common Stock

13/02/2018 - 02:57

SAN DIEGO, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE ), a clinical-stage, women’s biopharmaceutical company, today announced that it intends to offer primary shares of its common stock and [...]

MediciNova Announces Closing of Underwritten Public Offering of Common Stock

13/02/2018 - 00:30

LA JOLLA, Calif., Feb. 12, 2018 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV ) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875 [...]

Largest Shareholder of ZIVO Bioscience, Inc. to extend maturity date of its Convertible Debt

13/02/2018 - 00:09

KEEGO HARBOR, Mich., Feb. 12, 2018 (GLOBE NEWSWIRE) -- ZIVO Bioscience, Inc. (OTCMKTS:ZIVO) a biotech/agtech R&D company engaged in the commercialization of nutritional and medicinal products derived from [...]

BioTelemetry, Inc. to Release Fourth Quarter 2017 Earnings Results on February 22, 2018

12/02/2018 - 23:41

MALVERN, Pa., Feb. 12, 2018 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ: BEAT ) will release its fourth quarter 2017 earnings on Thursday, February 22 nd at 4:00 PM Eastern Time. The BioTelemetry quarterly conference [...]

Arcturus Therapeutics Appoints Dr. Christine Esau as Vice President of Research and Development

12/02/2018 - 23:30

Dr. Pad Chivukula Resigns as Chief Scientific Officer and Chief Operating Officer SAN DIEGO, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (NASDAQ: ARCT ), a leading RNA medicines company, today announced [...]

Dova Pharmaceuticals to Present at Leerink Partners 7th Annual Global Healthcare Conference

12/02/2018 - 23:00

DURHAM, N.C., Feb. 12, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA ) today announced that Alex Sapir, President and Chief Executive Officer, will present a company overview at the Leerink Partners [...]

MPX Announces Inclusion in Horizons Emerging Marijuana Growers Index ETF

12/02/2018 - 23:00

TORONTO, Feb. 12, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“ MPX ” or the “ Company ”) (CSE:MPX) (OTC:MPXEF) is pleased to announce its inclusion in the newly created Horizons Emerging Marijuana Growers [...]